Acrivon Therapeutics, Inc. Common Stock
USD1.75
-0.03 (-1.69%)
CEO
Peter Blume-Jensen
IPO Date
2022-11-15
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.76
Prev. Close
$1.78
Day Low
$1.74
Day High
$1.76
52W Low
$1.15
52W High
$3.56
Market Cap
$0.06B
Volume
0.04M
| -2.9 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -49.8% | -43.7% | 0.04 | 9.75 | -1.8 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -18.3% | -17.2% | 0.03 | 20.27 | -8.1 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | 68.2% | -15.2% | -0.24 | 34.46 | -13.2 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | 63.1% | -242.8% | -0.01 | 2.80 | -40.5 |
| -1.2 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -14.2% | -12.5% | 0.02 | 8.75 | -1.0 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -14.7% | -13.2% | 0.02 | 10.31 | -0.5 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -12.3% | -11.2% | 0.02 | 11.17 | -1.0 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -12.9% | -11.6% | 0.02 | 10.55 | -2.5 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -11.4% | -10.5% | 0.02 | 12.75 | -3.0 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -8.7% | -8.2% | 0.02 | 16.16 | -2.8 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -15.3% | -13.7% | 0.04 | 12.40 | -2.5 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -15.9% | -13.9% | 0.04 | 9.75 | -1.4 |